To the Editor, Asthma is a chronic heterogeneous inflammatory airway disease.Its treatment includes bronchodilators and anti-inflammatory medication such as corticosteroids. Corticosteroids reduce transcription of AP-1 and NF-κB and hence may affect DNA methylation.Epigenetics refers to changes in DNA that can affect transcription, such as methylation of a cytosine nucleotide beside a guanine nucleotide (CpGs).Asthma is associated with differentially methylated CpGs in specific genes. 1,2 In the largest study to date, asthmatic children had significantly lower blood methylation levels at 14 CpGs compared to controls. 3 One previous study found 19 CpGs that were differentially methylated in blood during systemic corticosteroid exposure in patients with COPD. 4 Possible effects of inhaled asthma medication on peripheral blood methylation profiles are currently unknown.Our aim was to study the association between inhaled corticosteroids and DNA methylation in peripheral blood cells in children with asthma. First, we performed an epigenome-wide association study (EWAS) investigating the effects of variable inhaled corticosteroid exposure on DNA methylation in 8-year-olds with diagnosed asthma in the BAMSE (Barn/Child, Allergy, Milieu, Stockholm, Epidemiology) cohort followed by replication attempts. Second, using a candidate gene approach, we evaluated if identified CpGs from the systemic steroid study 4 and the largest asthma study to date, 3 in total 33 CpGs, were differentially methylated in relation to inhaled asthma treatment.BAMSE is a Swedish prospective birth cohort study. 5 A total of 4089 children born 1994-1996 enrolled and information was collected in repeated questionnaires. Blood samples were taken at the